| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/21/1997 | EP0773944A1 Benzyl-imidazopyridines |
| 05/21/1997 | EP0773943A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 05/21/1997 | EP0773942A1 4-indole derivatives as serotonin agonists and antagonists |
| 05/21/1997 | EP0773940A1 Process for synthesis of substituted sulphoxides |
| 05/21/1997 | EP0773939A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/21/1997 | EP0773938A1 Semi-synthetic taxanes with anti-tumoural activity |
| 05/21/1997 | EP0773937A1 Novel aryl piperazine-derived piperazide derivatives, methods for their preparation, their use as drugs and pharmaceutical compositions comprising same |
| 05/21/1997 | EP0773933A1 Optically active isomers of dihydrexidine and its substituted analogs |
| 05/21/1997 | EP0773932A1 Benzenesulfonamide derivatives used as bradykinine antagonists |
| 05/21/1997 | EP0773931A1 Quinoline derivatives as leukotriene antagonists |
| 05/21/1997 | EP0773930A1 Aromatic amino ethers as pain relieving agents |
| 05/21/1997 | EP0773927A2 Benzoylguanidine derivatives as medicaments |
| 05/21/1997 | EP0773926A1 Difluorostatone antiviral agents |
| 05/21/1997 | EP0773795A1 Antifungal-wound healing compositions and methods for preparing and using same |
| 05/21/1997 | EP0773786A1 Quinoa saponin compositions and methods of use |
| 05/21/1997 | EP0773783A1 Preparation of fusidic acid tablets |
| 05/21/1997 | EP0773782A1 Terpenoidic derivatives (sarcodictyins) useful as antitumor agents |
| 05/21/1997 | EP0773780A1 Controlled release aqueous emulsion |
| 05/21/1997 | EP0674509A4 Methods for treatment with dimercaptosuccinic acid (dmsa). |
| 05/21/1997 | EP0660718A4 Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium. |
| 05/21/1997 | EP0650377A4 Implanting devices for release of neuroinhibitory compounds. |
| 05/21/1997 | EP0642514B1 Bridged bis-aryl carbinol derivatives, compositions and methods of use |
| 05/21/1997 | EP0623138B1 New adenosine derivatives, preparation methods and pharmaceutical compositions containing them |
| 05/21/1997 | EP0580738B1 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
| 05/21/1997 | EP0472725B1 Treatment of polycystic ovarian disease |
| 05/21/1997 | CN1150435A Process for removing bile salt from patient and alkylated compositions therefor |
| 05/21/1997 | CN1150433A Diagnosis, therapy and cellular and animal models for diseases associated with mitochondrial defects |
| 05/21/1997 | CN1150432A Maltitol composition and method for preparing same |
| 05/21/1997 | CN1150429A Cephalosporin compounds and processes for preparation thereof |
| 05/21/1997 | CN1150428A Corticotropin releasing factor antagonists |
| 05/21/1997 | CN1150426A Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents |
| 05/21/1997 | CN1150425A Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants |
| 05/21/1997 | CN1150424A Pyranone compounds useful to treat retroviral infections |
| 05/21/1997 | CN1150423A New taxoids, preparation thereof and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150422A Taxoids, preparation and pharmaceutical compositions containing them |
| 05/21/1997 | CN1150419A Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same |
| 05/21/1997 | CN1150389A Extracts of stephania tetrandra for inhibition of interleukin-6 production |
| 05/21/1997 | CN1150387A Pharmaceutical preparations and medicaments for prevention and treatment of endothelial dysfunction |
| 05/21/1997 | CN1150155A Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 05/21/1997 | CN1150153A Use of 2-amino-2,4,4,-trimethylpentane salt of clavulanic acid |
| 05/21/1997 | CN1150152A Process for manufacture of imidazo benzodiazepine derivatives |
| 05/21/1997 | CN1150151A Furan and furan amide compound and producing process and pharmaceutical composition thereof |
| 05/21/1997 | CN1150043A Efficient low-side effect external use medicine for curing seborrheic baldness |
| 05/21/1997 | CN1150021A Bowel clearing agent |
| 05/21/1997 | CN1150020A Anti-viral compounds |
| 05/21/1997 | CN1150019A Pharmaceutical combination preparation comprising ketoprofen |
| 05/21/1997 | CN1034942C Compound used as bone targetted drug with estrin structure |
| 05/21/1997 | CN1034940C Preparation process for new cephalosporin |
| 05/21/1997 | CN1034939C Process for preparing indolone and indoldione derivatives with cholinergic activity |
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/21/1997 | CN1034930C Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives and use thereof |
| 05/21/1997 | CN1034929C Ornithine decarboxylase inhibiting cyclic aminooxy compounds and use thereof |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190560A1 Process for producing vitamin d3 derivatives |
| 05/20/1997 | USRE35517 Method, compositions, and compounds for modulating brain excitability |
| 05/20/1997 | US5631402 Process for preparing aminobenzoic acid derivatives |
| 05/20/1997 | US5631394 Pharmaceutically active ceramide-related compounds |
| 05/20/1997 | US5631385 Using 2,2,6,6-tetramethylpiperidinyloxy free radical (tempo) |
| 05/20/1997 | US5631376 Retroviral protease inhibiting compounds |
| 05/20/1997 | US5631373 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| 05/20/1997 | US5631369 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 05/20/1997 | US5631366 Process for making 3-formylcephem derivatives |
| 05/20/1997 | US5631365 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/20/1997 | US5631355 Erythromycin derivatives |
| 05/20/1997 | US5631326 Crosslinked nitrogen-containing vinyl copolymers processes for their preparation and the use of these compounds |
| 05/20/1997 | US5631298 Growth promotion |
| 05/20/1997 | US5631297 Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same |
| 05/20/1997 | US5631296 Drugs containing S(+)-ibuprofen |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631289 Treatment of calcium deficiency and reducing irritation in intestines |
| 05/20/1997 | US5631288 Therapeutic method of treating patients suffering from AIDS and AIDS-related syndromes and asymptomatic HIV-seropositive patients. |
| 05/20/1997 | US5631287 Storage-stable prostaglandin compositions |
| 05/20/1997 | US5631286 Compounds useful for treating allergic or inflammatory diseases |
| 05/20/1997 | US5631284 Compositions and methods for relaxing smooth muscles |
| 05/20/1997 | US5631283 Use of sialic acid or antibodies to sialidase as anti-infectious agents and anti-inflammatory agents |
| 05/20/1997 | US5631282 Triterpenes |
| 05/20/1997 | US5631280 Inhibitors of farnesyl-protein transferase |
| 05/20/1997 | US5631279 Antagonists of neurokinin a |
| 05/20/1997 | US5631278 Methods of killing protozoal parasites |
| 05/20/1997 | US5631271 Treatment of enzyme defficiencies |
| 05/20/1997 | US5631269 Pyrazole, isooxazole or isothiazole piperidine derivatives |
| 05/20/1997 | US5631268 Antiallergens, 5ht2 receptor antagonists |
| 05/20/1997 | US5631267 Method for the treatment of eosinophil-associated diseases by administration of topical anesthetics |
| 05/20/1997 | US5631265 Chemical intermediates with central nervous system activity |
| 05/20/1997 | US5631264 Substituted 6,11-ethano-6,11-dihydrobenzo[B]quinolizinium salts and compositions and methods of use thereof |
| 05/20/1997 | US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| 05/20/1997 | US5631261 Triazoloquinazolines, their preparation and use |
| 05/20/1997 | US5631260 Xanthine epoxides as A1 adenosine receptor agonists and antagonists |
| 05/20/1997 | US5631259 Cycloalkltriols containing cyclic substituents, processes and intermediate products for their preparation and their use as antiviral and antiparasitic agents |
| 05/20/1997 | US5631258 Method of effecting immunosuppression by administering carbocyclic adenosine analogs |
| 05/20/1997 | US5631257 Benzoxazole derivatives |
| 05/20/1997 | US5631256 Antimicrobial quinolone thioureas |
| 05/20/1997 | US5631251 Cardiovascular disorders and antiarrthymia agents |
| 05/20/1997 | US5631249 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity |
| 05/20/1997 | US5631247 Antilipemic agents, cardiovascular disorders, urogenital disorders and osteoporosis |
| 05/20/1997 | US5631246 Use of PAF |
| 05/20/1997 | US5631245 Di-beta-glycopyranosylamine from glucose and nitrogen base |
| 05/20/1997 | US5631243 Protective lubricants for eye surgery which can easily be removed, in mixture with mucopolysaccharides |
| 05/20/1997 | US5631242 Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis |